ERBB2 and breast carcinoma: These data along with studies conducted by others that report reduced expression of LKB1 is correlated with poor prognosis [3], strongly support a role for LKB1 in breast cancer and suggest molecular interplay between LKB1 and HER2 signaling pathways in breast cancer.